ConductScience.org, home

Paper213976

Acyclic antimetabolite therapy of experimental herpes simplex keratitis.

Pavan-Langston D and 2 others. Am J Ophthalmol, 1978. Cited by 67 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Acyclic antimetabolite therapy of experimental herpes simplex keratitis. Papers, record 213976. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/213976

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Acyclic antimetabolite therapy of experimental herpes simplex keratitis.
PubMed
Journal
Am J Ophthalmol
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
67
iCite
Relative citation ratio, by iCite
3.74
iCite
Revised in PubMed
2019-06-27
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pavan-Langston DD
2Campbell RR
3Lass JJ

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
GuanosineMajor topic
Keratitis, DendriticMajor topic
Animals
Clinical Trials as Topic
Idoxuridine
Male
Rabbits
Simplexvirus
Vidarabine

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.

PMIDTitleJournalYearIn PapersSource
8695561Clinical evaluation of carbocyclic oxetanocin G eyedrops in the treatment of herpes simplex corneal ulcers.Br J Ophthalmol1996https://conductscience.org/library/papers/8695561PubMed
7352751(E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7352751PubMed
7043864A double-controlled evaluation of acyclovir and vidarabine for the treatment of herpes simplex epithelial keratitis.Trans Am Ophthalmol Soc1981https://conductscience.org/library/papers/7043864PubMed
7000171Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration.Br J Ophthalmol1980https://conductscience.org/library/papers/7000171PubMed
6809036Acyclovir and trifluorothymidine in herpetic keratitis: a multicentre trial.Br J Ophthalmol1982https://conductscience.org/library/papers/6809036PubMed
6785059Aciclovir and trifluorothymidine in herpetic keratitis. Preliminary report of a multicentered trial.Doc Ophthalmol1981https://conductscience.org/library/papers/6785059PubMed
6662013Acyclovir treatment in stromal herpetic keratitis.Doc Ophthalmol1983https://conductscience.org/library/papers/6662013PubMed
6315332Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.Drugs1983https://conductscience.org/library/papers/6315332PubMed
6303216Effects of prolonged cultivation in the presence of acyclovir on recovery of latent herpes simplex virus from human trigeminal ganglia.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6303216PubMed
6282195Acyclovir therapy of neonatal herpes simplex virus type 2 infections in rabbits.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6282195PubMed
6275777Quantitation of herpes simplex virus type 1 shed in preocular tear film of rabbits treated with acyclovir.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6275777PubMed
6251373Strategies of drug resistance in herpes simplex.Nature1980https://conductscience.org/library/papers/6251373PubMed
6249751Comparative in vitro imunotoxicology of acyclovir and other antiviral agents.Infect Immun1980https://conductscience.org/library/papers/6249751PubMed
6247967In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine).Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6247967PubMed
2991155Analysis of HSV isolated from patients with unilateral and bilateral herpetic keratitis.Int Ophthalmol1985https://conductscience.org/library/papers/2991155PubMed
2653790Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.Drugs1989https://conductscience.org/library/papers/2653790PubMed
2499895Rapid and accurate viral diagnosis.Pharmacol Ther1989https://conductscience.org/library/papers/2499895PubMed
1965619Herpes simplex virus ocular infections: current concepts of acute, latent and reactivated disease.Trans Am Ophthalmol Soc1990https://conductscience.org/library/papers/1965619PubMed
475362Therapy of experimental herpes simplex encephalitis with aciclovir in mice.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/475362PubMed
465415Efficacy of acycloguanosine against herpetic ulcers in rabbit cornea.Br J Ophthalmol1979https://conductscience.org/library/papers/465415PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/213976

GET https://conductscience.org/api/papers/v1/213976/authors